Clinical Trial Update: Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South Africa [Phase 1, Phase 2]

View source ↗

Summary

The Phase 1/2 trial evaluating safety and immunogenicity of VPM1002 vaccination or BCG revaccination for tuberculosis in HIV-infected and uninfected pre-adolesc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Tuberculosis

Drugs mentioned

• BCG vaccine (revaccination) (BCG vaccine)
• VPM1002 (recombinant Bacillus Calmette-Guérin vaccine (rBCG))

Snippet

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Conditions: Tuberculosis, HIV Infections | Phase 1, Phase 2 | Status: WITHDRAWN